John-Paul Denson
Frederick National Laboratory for Cancer Research(US)
Publications by Year
Research Areas
SARS-CoV-2 and COVID-19 Research, Nitric Oxide and Endothelin Effects, Cancer, Hypoxia, and Metabolism, COVID-19 Clinical Research Studies, Protein Kinase Regulation and GTPase Signaling
Most-Cited Works
- → KRAS interaction with RAF1 RAS-binding domain and cysteine-rich domain provides insights into RAS-mediated RAF activation(2021)241 cited
- → Serologic Cross-Reactivity of SARS-CoV-2 with Endemic and Seasonal Betacoronaviruses(2021)189 cited
- → Standardization of ELISA protocols for serosurveys of the SARS-CoV-2 pandemic using clinical and at-home blood sampling(2021)162 cited
- → Undiagnosed SARS-CoV-2 seropositivity during the first 6 months of the COVID-19 pandemic in the United States(2021)138 cited
- → K-Ras4B Remains Monomeric on Membranes over a Wide Range of Surface Densities and Lipid Compositions(2018)85 cited
- → Optimizing Expression and Solubility of Proteins in E. coli Using Modified Media and Induction Parameters(2017)79 cited
- → Serologic cross-reactivity of SARS-CoV-2 with endemic and seasonal Betacoronaviruses(2020)53 cited
- → Standardization of enzyme-linked immunosorbent assays for serosurveys of the SARS-CoV-2 pandemic using clinical and at-home blood sampling(2020)43 cited
- → Discovery of BBO-8520, a First-In-Class Direct and Covalent Dual Inhibitor of GTP-Bound (ON) and GDP-Bound (OFF) KRASG12C(2024)35 cited
- → Improved production of SARS-CoV-2 spike receptor-binding domain (RBD) for serology assays(2020)34 cited